Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
7,331 total articles
Itron President and CEO Deitrich Thomas sold 1,772 shares on February 24, 2026, for $94.8147 per share, generating $168,011 to satisfy tax withholding tied to a restricted stock unit vesting. The filing shows Thomas now directly holds 370,301 shares and indirectly holds 25,000 more through a trust. The transaction comes after Itron reported fourth-…
Amkor Technology Executive Vice President Farshad Haghighi reported a sale of 15,624 shares on February 25 for $50.50 per share, generating $789,012. The SEC filing shows additional transactions tied to restricted stock unit activity and tax withholding. These insider moves occur alongside robust fourth-quarter 2025 results, a significant secondary…
Emily Yang, senior vice president for worldwide sales and marketing at Diodes Incorporated, reported the sale of 2,154 shares of DIOD on February 24, 2026, for $150,550, according to a Form 4 filing. The transaction happened as Diodes shares have climbed more than 41% year-to-date and trade near $69.63. The company also released fourth-quarter 2025…
Jennifer N. Jones, Coinbase Global's chief accounting officer, sold 1,102 Class A shares on February 24, 2026, for a total of $170,122 under a Rule 10b5-1 plan. The sales occurred across several price points as the company reports a revenue decline and a net loss, while expanding product offerings such as stock trading for U.S. users.
ViaSat Chief Accounting Officer Camellia E. FitzGerald sold 1,119 shares of the company's common stock on February 25, 2026, for $50.00 per share, totaling $55,950. The sale was executed under a Rule 10b5-1 plan adopted December 12, 2025, and occurred close to the stock's 52-week high. FitzGerald retains 8,827 shares directly and indirectly holds 2…
Lorrain Daniel S., Chief Scientific Officer of Contineum Therapeutics (NASDAQ: CTNM), sold 8,124 Class A shares on February 24 and 25, 2026, netting $130,163 at weighted average prices between $16.0115 and $16.0316 per share. The transactions followed the exercise of options to acquire the same 8,124 shares at $1.01 per share, a cost of $8,205. The…
Kate Eileen Suhadolnik, chief financial officer of ESS Tech, Inc. (NYSE: GWH), sold 741 shares on February 20, 2026, to satisfy tax withholding tied to vested restricted stock units. The trade totaled $1,141 and left her with 164,414 shares directly held, including restricted stock units. The transaction unfolds against a backdrop of cash burn, a w…
Tim McCauley, Chief Accounting Officer of Chefs' Warehouse, Inc. (NASDAQ: CHEF), sold 7,500 shares on February 18, 2026, for $525,000 as the stock traded close to its 52-week high. Subsequent filings show additional share purchases, tax-withholdings and a consolidated ownership position of 50,025 shares. The company posted stronger-than-expected fo…
Kelly F. Goodman, Chief Strategy Officer and General Counsel at ESS Tech, Inc. (NYSE: GWH), sold 2,269 shares on February 20, 2026 to satisfy tax withholding tied to restricted stock unit vesting. The transaction, executed at $1.54 per share, yielded $3,494. ESS Tech has recently raised roughly $15 million in a registered direct offering, acquired …
FVCBankcorp EVP and Chief Banking Officer Sharon L. Jackson sold 1,000 shares of company common stock on February 25, 2026, for $15.49 per share, a transaction valued at $15,490. The bank recently declared a $0.06 quarterly cash dividend and reported that Atlantic Coast Mortgage - a firm in which FVCBankcorp holds a minority stake - has acquired Ti…
TrueBlue CEO and President Taryn R. Owen purchased 20,400 shares of the company on February 24, 2026, spending $77,316 across multiple trades priced between $3.60 and $3.84. The purchase brings Owen's direct holding to 791,807 shares as the stock trades near a 52-week low. Separately, TrueBlue announced leadership changes at its PeopleReady busines…
Vir Biotechnology CEO Marianne De Backer sold 14,762 shares on February 24, 2026, in an automatic trade under a Rule 10b5-1 plan to cover tax withholding tied to restricted stock unit vesting. The transaction totaled about $140,720 at an average price of $9.5326 per share. The move coincides with recent financing steps and clinical progress, includ…
Hershey Co. executive Jason Reiman sold 2,000 shares of common stock on February 24, 2026, for $226.07 a share, a transaction totaling $452,140. The sale was carried out under a Rule 10b5-1 trading plan implemented on November 18, 2025. Hershey's stock is trading near its 52-week high amid upbeat fourth-quarter results and optimistic 2026 earnings …
Larry W. Myers, a director and First Vice President at First Merchants Corporation, sold 5,000 shares on February 26, 2026, for $41.50 per share. The sale follows the company's stronger-than-expected fourth-quarter results and a declared quarterly dividend. Myers retains substantial direct and indirect holdings and joined the First Merchants board …
Thomas W. Powell, identified as a 10% owner of Powell Industries (POWL), executed multiple transactions selling a total of 1,479 shares of common stock on February 24 and 25, 2026, according to a Form 4 filed with the SEC. The sales, which generated $828,905, were completed at prices ranging from $560.3004 to $563.651. The insider reduction follows…
Chad Patterson, Chief Communications & Product Officer at iRhythm Holdings, sold 8,967 shares on February 25, 2026, for roughly $1.2 million, according to a Form 4 filing. After the sale Patterson directly held 51,738 shares. The day before the sale he was credited with 17,318 shares at a value of $0 after the board committee determined performance…
Catherine E. Dunn, Vice President and Chief Accounting Officer of Oceaneering International Inc (OII), sold a total of 9,645 shares across transactions on February 24-25, 2026, realizing proceeds of $362,982. Insider sales occurred while the stock traded close to its 52-week peak and after the company reported fourth-quarter 2025 earnings that beat…
iRhythm Holdings Inc. Chief Financial Officer Daniel G. Wilson sold 5,188 shares on February 25, 2026, for $135.42 each, generating $702,553 in proceeds. The day prior he received 9,412 shares at no cost after the company’s compensation committee determined performance conditions tied to 2023 restricted stock units had been met. The transactions le…
Kristen Ambrose, Senior Vice President and Chief Accounting Officer at Vertex Pharmaceuticals (VRTX), reported a sale of 223 shares on February 25, 2026, under a company-approved 10b5-1 plan. The transaction, along with an earlier disposal on February 24, 2026, leaves Ambrose with 6,981 shares. The company’s shares trade near $480 while recent quar…
Xometry Inc. Chief Technology Officer Raghavan Vaidyanathan sold 4,572 Class A shares on February 26, 2026, for about $198,625 to satisfy tax withholding tied to vested restricted stock units. The trades were automatic under a Rule 10b5-1 plan. The transactions follow a February 24, 2026 vesting of 30,479 RSUs at $0.00 and leave Vaidyanathan with 6…
Uma M. Amuluru, Boeing's Executive Vice President and Chief Human Resources Officer, sold 1,503.45 shares of company stock on February 24, 2026, generating about $351,484. The transaction was reported on a Form 4 filing with the Securities and Exchange Commission. The sale occurred as Boeing stock has risen 32% over the past year, though InvestingP…
Donald E. Bobo Jr., Corporate Vice President for Strategy and Corporate Development at Edwards Lifesciences Corp (NYSE: EW), sold 24,000 shares on February 25, 2026, bringing in $2,012,076 at a weighted average price of $83.8365. The sale occurred while the stock trades close to its 52-week peak and follows the company’s mixed fourth-quarter 2025 f…
Xometry Chief Executive Randolph Altschuler sold 25,628 Class A shares on February 26, 2026, in automated transactions tied to a pre-established Rule 10b5-1 plan to meet tax-withholding obligations from vested restricted stock units. The company also reported Q4 2025 results that beat consensus on both earnings and revenue.
David C. Abrams, a director and ten percent owner of ContextLogic Holdings Inc (NASDAQ: LOGC), filed a Form 4 disclosing a purchase of 1,758,794 shares on February 26, 2026. The shares were acquired at $7.00 each for a total of $12,311,558. After the transaction, Abrams directly and indirectly holds 18,269,534 shares. The purchase was reported seve…
BioMarin Pharmaceutical Inc. EVP and Chief R&D Officer Gregory R. Friberg sold 6,326 shares on February 26, 2026 for a weighted average price of $60.3758, totaling $381,937. The transaction left him with 37,578 shares. Separately, BioMarin reported fourth-quarter 2025 results that missed EPS estimates but topped revenue expectations, prompting a ra…
